1. Dopamine agonist-based strategies in the treatment of Parkinson’s disease

   • Angelo Antonini
   • Paolo Barone

   OriginalPaper 21 April 2009 Pages: 371 - 374

2. Dopamine agonists and therapy compliance

   • Donald Grosset

   OriginalPaper 21 April 2009 Pages: 375 - 376

3. Optimising levodopa therapy

   • Giovanni Abbruzzese

   OriginalPaper 21 April 2009 Pages: 377 - 379

4. Clinical experience of tolcapone in advanced Parkinson’s disease

   • Margherita Canesi
   • Anna Lena Zecchinelli
   • Angelo Antonini

   OriginalPaper 21 April 2009 Pages: 380 - 382

5. Use of apomorphine in Parkinson’s disease

   • Fabrizio Stocchi

   OriginalPaper 21 April 2009 Pages: 383 - 386

6. Continuous dopaminergic stimulation achieved by duodenal levodopa infusion

   • Per Odin
   • Erik Wolters
   • Angelo Antonini

   OriginalPaper 21 April 2009 Pages: 387 - 388

7. Subthalamic nucleus stimulation in Parkinson’s disease

   • Roberto Marconi
   • Andrea Landi
   • Franco Valzania

   OriginalPaper 21 April 2009 Pages: 389 - 391

8. The rationale for improved integration between home care and neurology hospital services in patients with advanced Parkinson’s disease

   • Angelo Antonini
   • Luisa Mirò
   • Gianni Pezzoli

   OriginalPaper 21 April 2009 Pages: 392 - 396